Abstract
The Kell blood group system was named after the person who made the first recognized antibody. Other than ABO, the Kell antigens are perhaps only second to the D antigen in the Rh system as potent immunogens. About 5% of K:−1 persons who are transfused with a single unit of K:1 red cells make anti-K1 IgG. The Kell blood group system is important not only in transfusion but also clinically since K1 is present on red cells of fetuses and maternal alloimmunization may cause hemolytic disease in the newborn.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Allen, F. H., Krabbe, S. M. R., and Concoran. P. A., 1961, A new phenotype (McLeod) in the Kell blood-group system. Vox Sang. 6: 555–560.
Anstee, D. J., 1990, Blood group-active surface molecules of the human red blood cells, Vox Sang. 58: 1–20.
Ballas, S. K., Bator. S. M.. Aubuchon. J. P., Marsh, W. L., Sharp, D. E., and Toy, E. M., 1990. Abnormal membrane physical properties of red cells in McLeod syndrome, Transfusion. 30: 722–727.
Bertelson, C. J., Pogo, A. O., Chadhuri, A., Redman, C. M., Banerjee, D.. Symmans, W. A., Simon, T., and Kunkel, L. M., 1988, Localization of the McLeod locus (XK) within Xp21 by deletion analysis, Am. J. Hum. Genet. 423: 703–711.
Branch, D. R.. and Petz, L. D., 1982, A new reagent (ZZAP) having multiple applications in immunohematology, Am. J. Clin. Pathol. 78: 161–167.
Branch, D. R., Muensch, H. A., Siok Hian, H. L. S.. and Petz, L. D., 1983, Disulfide bonds are a requirement for Kell and Cartwright (Yta) blood group antigen integrity, Br. J. Haematol. 54: 573–578.
Chou, P. Y., and Fasman. G. D., 1978, Empirical predictions of protein conformation. Annu. Rev. Biochem. 47: 251–276.
Clarke, S., 1992, Protein isoprenylation and methylation at carboxyl-terminal cysteine residues. Annu. Rev. Biochem. 61: 355–386.
Connelly, J. C., Skidgel, A., Schultz, W. W.. Johnson. A. R., and Erdos. E. G., 1985, Neutral endopeptidase 24.11 in human neutrophils: Cleavage of chemotactic peptide, Proc. Natl. Acad. Sci. USA 82: 8737–8741.
Engelman, D. M., Steitz. T. A.. and Goldman, A., 1986. Identifying nonpolar transbilayer helices in amino acid sequences of membrane proteins, Annu. Rev. Biophys. Biophys. Chem. 15: 321–353.
Francke, U., Ochs, H. D.. de Martinville, B., Giacalone, J., Lindgren, V., Disteche, C. M., Pagan, R. A., Hofker, M. H., van Ommen. G. J. B., Pearson, P. L., and Wedgewood, R. J., 1985, Minor Xp21 chromosome deletion in a male associated with expression of Duchenne muscular dystrophy, chronic granulomatous disease, retinitis pigmentosa and the McLeod syndrome. Am. J. Hum. Genet. 37: 250–267.
Gafford, J. T., Skidgel, R. A., Erdos, E. G., and Hersh, L. B., 1983, Human kidney “enkephalinase” a neutral metalloendopeptidase that cleaves active peptides, Biochemistry 22: 3265–3271.
Galey, W. R., Evan, A. P., VanNice. P. S., Dail, W. G.. Wirner, B. M., and Cooper, R. A. 1978. Morphology and physiology of the McLeod Erythrocyte: I. Scanning electron microscopy and electrolyte and water transport properties. Vox Sang. 34: 152–161.
Getman, D. K., Eubanks, J. H., Camp. S., Evans, G. A., and Taylor, P. 1992, The human gene encoding acetylcholinesterase is located on the long arm of chromosome 7. Am. J. Hum. Genet. 51: 170–177.
Glaubensklee, C. S., Evan, A. P., and Galey, W. R., 1982, Structural and biochemical analysis of the McLeod erythrocyte membrane. I. Freeze fracture and discontinuous polyacrylamide gel electrophoresis analysis. Vox Sang. 42: 262–271.
Ho, M. F., Monaco, A. P.. Blouden, L. A. J., Van Ommen, G. J. B.. Affara, N. A.. Ferguson-Smith, M. A., and Lehrach, H.. I992a, Fine mapping of the McLeod locus (XK) to a 150–350 kb region in Xp21, Am. J. Hum. Genet. 50: 317–330.
Ho, M. F., Clarke. J., Chelly, J., and Monaco. A. P., 19926, Isolation of cDNA clones from the McLeod syndrome critical region, Annual meeting of the American Society of Human Genetics (Abstract) A21.
Ho, M.. Chelly, J., Carter, N., Dane. K. A., Crocker, P., and Monaco, A. P., 1994, Isolation of the gene for McLeod syndrome that encodes a novel membrane transport protein, Cell 77: 869–880.
Jaber, A., Blanchard, D., Goossens, D., Bloy, C., Lambin, P.. Rouger, P., Salmon, C., and Cartron, J.-P., 1989, Characterization of blood group Kell (KI) antigen with a human monoclonal antibody, Blood. 73: 1597–1602.
Hughes-Jones, N. C., and Gardner, B.. 1971, The Kell system: studies with radiolabeled anti-K. Vox Sanguinis 21: 154–158.
Jaber, A., Loirat, M. J., Willem, C., Bloy, C., Cartron, J.-P., and Blanchard. D., 1991, Characterization of murine monoclonal antibodies directed against the Kell blood group glycoprotein, Br. J. Haematol. 79: 311–315.
Kenny, A. J., O’Hare, M. J.. and Gusterson, B. A., 1989, Cell surface peptidases as modulators of growth and differentiation, Lancet 2: 785–787.
Khodadad, J. K., Weinstein, R. S. Marsh, W. L., and Steck, T. L.. 1989. Shape determinants of McLeod acanthocytes, J. Membr. Biol. 107: 213–218.
Kuypers, F. A., Van Linde Sibenius Trip, M., Roelofsen, B., Opdenkamp, J. A. F.,Tanner, M. J. A., and Anstee, D. J., 1985, The phospholipid organizations in the membranes of McLeod and Leach phenotype erythrocytes, Fed. Eur. Biochem. Soc. 184:20–24.
Lee, S., and Redman. C., 1988, Kell blood group proteins, J. Cell Biol. 197: 560a (abstract).
Lee, S., Zambas, E., Marsh, W. L., and Redman, C. M., 1991, Molecular cloning and primary structure of Kell blood group protein, Proc. Nat!. Acad. Sci. USA 88: 6353–6357.
Lee, S., Zambas, E. D., and Redman. C. M., 1992, Characterization of the gene encoding the human Kell blood group antigens, Mol. Biol. Cell 3: 81a (abstract).
Lee, S., Zambas, E. D., Marsh, W. L., and Redman, C. M., 1993, The human Kell blood group gene maps to 7833 and its expression is restricted to erythroid cells. Blood 10: 2804–2809.
Letarte, M., Vera, S.. Tran, R., Addis, J. B. L., Onizuka, R. J., Quackenbush, E. J.. Jongeneel, C. V., and McInnes, R. R., 1988. Common acute lymphocytic leukemia antigen is identical to neutral endopeptidase, J. Exp. Med. 168: 1247–1253.
Lozzio, C. B., and Lozzio, B. B.. 1975, Human chronic myelogenous leukemia cell line with positive Philadelphia chromosome, Blood 45: 321–334.
McGinness, M. H., and Dean, A., 1985, Expression of red cell antigens by K562 human leukemia cells before and after induction of hemoglobin synthesis by hemin, Transfusion 25: 105–109.
Malfroy, B., Kuang, W.-J., Seeburg. P. H., Mason, A. J., and Schofield, P. R., 1988, Molecular cloning and amino acid sequence of human enkephalinase (neutral endopeptidase), FEBS Lett. 229: 206–210.
Marsh, W. L., and Redman, C. M., 1987, Recent developments in the Kell blood group system, Trans-fus. Med. Rev. 1: 4–20.
Marsh, W. L., and Redman, C. M., 1990, The Kell blood group system: A review, Transfusion 30: 158–167.
Marsh, W. L., Oyen, R., Nichols, M. E., and Allen, F. H., 1975, Chronic granulomatous disease and the Kell blood groups, Br. J. Haematol. 29: 247–262.
Marsh, W. L., Marsh, N. J., Moore, A., Symmans, W. A., Johnson, C. L., and Redman, C. M., 1981, Elevated serum creative phosphokinase in subjects with McLeod syndrome, Vox Sang. 40: 403–411.
Masouredis, S. P., Sudora, E.. Mohan, L. C., and Victoria, E. J., 1980, Immunoelectron microscopy of Kell and Cellano antigens on red cell ghosts, Haematologia 13: 59–64.
Parsons, S. F., Gardner, B., and Anstee, D. J., 1993, Monoclonal antibodies against Kell glycoprotein: serology, immunochemistry and quantitation of antigen sites, Transfus. Med. 3: 137–142.
Rao, H., Whitsett, C. F., Oxendine, S. M., and Telen, M. J., 1993, Human erythrocyte acetylcholinesterase bears the Yt blood group antigen and is reduced or absent in the Yt (a— b—) phenotype. Blood 81: 8–15.
Redman, C. M., Marsh, W. L., Mueller, K. A., Avellino, G. P., and Johnson, C. L., 1984, Isolation of Kell-active protein from the red cell membrane, Transfusion 24: 176–178.
Redman, C. M., Avellino, G., Pfeffer, S. R., Mukherjee, T. K., Nichols, M., Rubinstein, P., and Marsh, W. L., 1986, Kell blood group antigens are part of a 93,000 dalton red cell membrane protein, J. Biol. Chem. 261: 9521–9525.
Redman, C. M., Marsh, W. L., Scarborough, A., Johnson, C. L., Rabin, B. I., and Overbeeke, M., 1988, Biochemical studies on McLeod phenotype red cells and isolation of Kx antigen. Br. J. Haematol. 68: 131–136.
Redman, C. M., Huima, T., Robbins, E., Lee, S., and Marsh, W. L., 1989a, Effect of phosphatidylserine on the shape of McLeod red cell acanthocytes. Blood 74: 1826–1835.
Redman, C. M., Lee, S., Ten Bokkel Huinink, D., Rabin, B. 1., Johnson, C. L., Oyen, R., and Marsh, W. L., 1989b, Comparison of human and chimpanzee Kell blood group systems, Transfusion 29: 486–490.
Russo, D., Lee, S., and Redman, C. M., 1993, Transfected cells express a Kell blood group protein with multiple antigens, Am. Soc. Cell Biol. (abstract).
Shipp, M. A., Richardson, N. E., Sayre, P. H., Brown, N. R., Masteller, E. L., Clayton, L. K., Ritz, J., and Reinherz, E. L., 1988, Molecular cloning of the common acute lymphoblastic leukemia antigen (CALLA) identifies a type II integral membrane protein, Proc. Nail. Acad. Sci. USA 85: 4819–4823.
Shipp, M. A., Vijayaraghavan. J., Schmidt, E. V., Masteller, E. L., D’Adamio, L. B., Hersh, L. D., and Reinherz, E. L.. 1989, Common acute lymphoblastic antigen (CALLA) is active neutral endopeptidase 24.11 (`enkephalinase“): Direct evidence by cDNA transfected analysis, Proc. Natl. Acad. Sci. USA 86: 297–301.
Spence, M. A., Falk, C. T., Neiswanger, K., Field, L. L.. Marazita, M. L., Allen, F. H., Siergovel, R. M., Roche, A. F., Cradall, B. F., and Sparkes. R. S., 1984, Estimating the recombination frequency for the PTC-Kell linkage. Hum. Genet. 678: 183–186.
Spring, F. A., and Anstee, D. J. 1991. Evidence that Yt blood group antigens are located on human acetyldrolinesterase (AchE), Transfus. Med. Res. 1: 42 (Abstract suppl. 2).
Symmans, W. A., Shepherd, C. S., Marsh, W. L., Oyen, R., Shohet. S. B., and Linehan, B. J., 1979, Hereditary acanthocytosis associated with the McLeod phenotype of the Kell blood group system, Br. J. Haematol. 42: 575–583.
Tang, L. L., Redman, C. M., Williams, D., and Marsh. W. L., 1981, Biochemical studies on McLeod phenotype erythrocytes. Vox Sang. 40: 17–26.
Wainfan, E.. Kilkenny, M.. Johnson, C., and Marsh, W. L.. 1991. Reduced membrane protein methylation in red cells of the McLeod blood group phenotype, Transfusion 31: 805–809.
Wimmer, B. M., Marsh. W. L., Taswell, H. F., and Galey, H. R.. 1977, Haematological changes associated with the McLeod phenotype of the Kell blood group system, Br. J. Haematol. 36: 219–224.
Wu, Q., Lahti, J. M., Air, G. M., Burrows, P. D.. and Cooper, M. D., 1990. Molecular cloning of the murine Bp-1/6C3 antigen: A member of the zinc-dependent metallopeptidase family. Proc. Natl. Acad. Sci. USA 87: 993–997.
Zelinski, T., Coghlan, G., Myal, L., Shin, R. P. C., Philips, S., White, L., and Lewis. M. 1991, Genetic linkage between the Kell blood group system and prolactin-inducible protein loci: provisional assignment of KEL to chromosome 7, Ann. Hum. Genet. 55: 137–140.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1995 Springer Science+Business Media New York
About this chapter
Cite this chapter
Redman, C.M., Lee, S. (1995). Kell Blood Group System and the McLeod Syndrome. In: Cartron, JP., Rouger, P. (eds) Molecular Basis of Human Blood Group Antigens. Blood Cell Biochemistry, vol 6. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-9537-0_7
Download citation
DOI: https://doi.org/10.1007/978-1-4757-9537-0_7
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-306-44853-9
Online ISBN: 978-1-4757-9537-0
eBook Packages: Springer Book Archive